Expression and clinical significance of the CD47/SIRPα pathway as a candidate immunotherapy target in non-small cell lung cancer (NSCLC)

被引：0
|
作者：
Desai, Shruti [1 ]
Villarroel-Espindola, Franz [1 ]
Gaule, Patricia [1 ]
Ducler, Adam [1 ]
Peluso, Marisa [2 ]
Lee, Benjamin [2 ]
Schalper, Kurt [1 ]
Holland, Pamela [2 ]
机构：
[1] Yale Univ, Sch Med, New Haven, CT USA
[2] Surface Oncol, Cambridge, MA USA
来源：
JOURNAL FOR IMMUNOTHERAPY OF CANCER | 2019年 / 7卷
关键词：
D O I：
暂无
中图分类号：
R73 [肿瘤学];
学科分类号：
100214 ;
摘要：
P270
引用
收藏
页数：1
相关论文
共 50 条
  • [31] Clinical significance of HuR expression, an mRNA-binding protein in non-small cell lung cancer (NSCLC).
    Tanaka, F.
    Ogawa, E.
    Wada, H.
    Shanker, M.
    Garcia-Soto, A. E.
    Branch, C. D.
    Wistuba, I.
    Roth, J. A.
    Ramesh, R.
    JOURNAL OF CLINICAL ONCOLOGY, 2006, 24 (18) : 565S - 565S
  • [32] Clinical significance of cannabinoid receptor CB2 expression in non-small cell lung cancer (NSCLC)
    Tsoukalas, N. G.
    Giaginis, C.
    Alexandrou, P.
    Liontos, M.
    Tolia, M.
    Kiakou, M.
    Sfiniadakis, I.
    Kavantzas, N.
    Patsouris, E.
    Theocharis, S.
    ANNALS OF ONCOLOGY, 2020, 31 : S1115 - S1115
  • [33] Clinical significance of programmed death ligand-1 expression in non-small cell lung cancer (NSCLC)
    Velcheti, Vamsidhar
    Schalper, Kurt
    Carvajal, Daniel
    Chen, Lieping
    Sznol, Mario
    Gettinger, Scott N.
    Herbst, Roy S.
    Rimm, David
    JOURNAL OF CLINICAL ONCOLOGY, 2013, 31 (15)
  • [34] Expression of placenta growth factor (PIGF) in non-small cell lung cancer (NSCLC) and the clinical and prognostic significance
    Zhang L.
    Chen J.
    Ke Y.
    Mansel R.E.
    Jiang W.G.
    World Journal of Surgical Oncology, 3 (1)
  • [35] CD47 Expression and Prognosis in Patients with Small Cell Lung CancerCD47 Expression and Prognosis in Patients with Small Cell Lung Cancer
    Hernandez-Pedro, N.
    Orozco-Morales, M.
    Aviles-Salas, A.
    Cabrera-Miranda, L.
    Ramirez-Tirado, L.
    Barrios-Bernal, P.
    Arrieta, O. G.
    JOURNAL OF THORACIC ONCOLOGY, 2019, 14 (10) : S1022 - S1022
  • [36] Evaluating CD38 as a therapeutic target in non-small cell lung cancer (NSCLC)
    Kinder, Michelle
    Mendonca, Mark
    Syed, Khaja
    Parker, Melissa
    Wilkinson, Patrick
    Thompson, Edward
    Chu, Gerald
    Chiu, Christopher
    Hutnick, Natalie
    JOURNAL FOR IMMUNOTHERAPY OF CANCER, 2017, 5
  • [37] Expression and clinical significance of aminopeptidase N/CD13 in non-small cell lung cancer
    Zhang, Quan
    Wang, Jinghui
    Zhang, Haiqing
    Zhao, Dan
    Zhang, Zongde
    Zhang, Shucai
    JOURNAL OF CANCER RESEARCH AND THERAPEUTICS, 2015, 11 (01) : 223 - 228
  • [38] Combination of CD47 and CD68 expression predicts survival in eastern-Asian patients with non-small cell lung cancer
    Fu, Fangqiu
    Zhang, Yang
    Gao, Zhendong
    Zhao, Yue
    Wen, Zhexu
    Han, Han
    Li, Yuan
    Hu, Hong
    Chen, Haiquan
    JOURNAL OF CANCER RESEARCH AND CLINICAL ONCOLOGY, 2021, 147 (03) : 739 - 747
  • [39] Combination of CD47 and CD68 expression predicts survival in eastern-Asian patients with non-small cell lung cancer
    Fangqiu Fu
    Yang Zhang
    Zhendong Gao
    Yue Zhao
    Zhexu Wen
    Han Han
    Yuan Li
    Hong Hu
    Haiquan Chen
    Journal of Cancer Research and Clinical Oncology, 2021, 147 : 739 - 747
  • [40] Immunotherapy in Non-Small Cell Lung Cancer (NSCLC) - Experiences from Clinical Practice - Sweden
    Koyi, H.
    Isaksson, J.
    Vikstrom, A.
    Ohman, R.
    Xanthoulis, P.
    Rosberg, A.
    Branden, E.
    JOURNAL OF THORACIC ONCOLOGY, 2019, 14 (10) : S982 - S982
12345